Cookson Peirce & CO Inc Alnylam Pharmaceuticals, Inc. Transaction History

Cookson Peirce & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$120.42 - $169.29 $1.25 Million - $1.76 Million	-10,403 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$127.18 - $173.91 $85,846 - $117,389	675 Added 6.94%	10,403 $1.7 Million
Q4 2021 Jan 31, 2022	BUY	$159.56 - $209.29 $79,780 - $104,645	500 Added 5.42%	9,728 $1.65 Million
Q3 2021 Nov 04, 2021	BUY	$169.75 - $207.73 $1.57 Million - $1.92 Million	9,228 New	9,228 $1.74 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.